Avidity Partners Management’s Merck MRK Stock Holding History

Avidity Partners Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-325,000	Closed	-$40.2M	–	94
2024 Q2	$40.2M	Sell	325,000 -177,000	-35%	-$22.8M	1.71%	21
2024 Q1	$66.2M	Buy	+502,000	New	+$61.9M	2.14%	13
2023 Q2	–	Sell	-600,000	Closed	-$63.8M	–	104
2023 Q1	$63.8M	Buy	+600,000	New	+$64.8M	2.12%	19
2022 Q2	–	Sell	-2,370,000	Closed	-$194M	–	93
2022 Q1	$194M	Buy	+2,370,000	New	+$187M	4.05%	6
2020 Q4	–	Sell	-1,199,226	Closed	-$94.9M	–	111
2020 Q3	$94.9M	Buy	+1,199,226	New	+$93.9M	4.4%	5
2020 Q2	–	Sell	-515,616	Closed	-$37.9M	–	71
2020 Q1	$37.9M	Buy	+515,616	New	+$40.5M	5.23%	2

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Avidity Partners Management's MRK Position: Q3 2024 in Review

Avidity Partners Management sold out of Merck (MRK) in Q3 2024, closing a stake of 325,000 shares — an estimated $40.2M sold.

Avidity Partners Management first reported a position in MRK in Q1 2020 and held it in 6 quarters. The position peaked at $194M in Q1 2022. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

Avidity Partners Management reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
Avidity Partners Management sold 325,000 Merck shares in Q3 2024, an estimated $40.2M.
Avidity Partners Management first reported a position in Merck in Q1 2020 and held it in 6 quarters.
Avidity Partners Management's Merck position peaked at $194M in Q1 2022.
3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Avidity Partners Management's 13F filing for Q3 2024, filed 14 Nov 2024.